Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer
Clinical trial NCT00113789 · COMPLETED
Trial details
- NCT number
- NCT00113789
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2005-04-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.